OTC Healthcare in Italy

Table of Contents

• OTC HEALTHCARE IN ITALY : MARKET INSIGHT
• EXECUTIVE SUMMARY
• OPERATING ENVIRONMENT
• OTC Registration and Classification
  • Table 1 Number of Prescriptions Issued 2000-2005
• Vitamins & Dietary Supplements Registration and Classification
• Advertising
• Packaging and Labelling
• Distribution
• De-listing or De-reimbursement
• Traditional Remedies
• Homeopathy
  • Table 2 Retail Sales of Homoeopathy 2000-2004
• Generics
• Consumer Expenditure on Health Goods and Medical Services
  • Table 3 Consumer Expenditure on Health Goods and Medical Services 2000-2005
• Life Expectancy
  • Table 4 Life Expectancy at Birth 2000-2005
• OTC HEALTHCARE SALES
• Market Performance
  • Table 5 Sales of OTC Healthcare by Sector: Value 2000-2005
  • Table 6 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
• Switches
  • Table 7 OTC Healthcare Switches 2003-2005
• Key Trends and Developments
• Competitive Environment
  • Table 8 OTC Healthcare Company Shares by Retail Value 2001-2005
  • Table 9 OTC Healthcare Brand Shares by Retail Value 2002-2005
• Retail Distribution
  • Table 10 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
  • Table 11 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
• Retailer Activity and Private Label Trends
  • Table 12 Penetration of Private Label by Sector 2001-2005
• Forecast Market Performance
  • Table 13 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
  • Table 14 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
• DEFINITIONS
• LOCAL COMPANY PROFILES - ITALY
• A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL - OTC
• HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 1 Summary - A Menarini Industrie Farmaceutiche Riunite Srl Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 15 A Menarini Industrie Farmaceutiche Riunite Srl: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• ABOCA SAS - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• ARKOFARM SRL - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 2 Summary - ACRAF-Gruppo Angelini: Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
• STRENGTHS
• WEAKNESSES
• OPPORTUNITIES
• THREATS
  • Table 16 ACRAF-Gruppo Angelini: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• BAYER SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 3 Summary - Bayer SpA Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 17 Bayer SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• BODY SPRING SRL - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• BOEHRINGER INGELHEIM ITALIA SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 4 Summary - Boehringer Ingelheim Italia SpA: Operational Indicators 2004
• PRODUCTION CAPACITY
  • Summary 5 Summary - Boehringer Ingelheim Italia SpA: Production Statistics 2004
• COMPETITIVE POSITIONING
  • Table 18 Boehringer Ingelheim Italia SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• BRACCO SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 6 Summary - Bracco SpA: Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 19 Bracco SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• CHIESI FARMACEUTICI SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 7 Summary - Chiesi Farmaceutici SpA: Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 20 Chiesi Farmaceutici SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• FARMILA FARMACEUTICI MILANO SPA - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• GLAXOSMITHKLINE SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 8 Summary - GlaxoSmithKline SpA : Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 21 GlaxoSmithKline SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• JOHNSON & JOHNSON SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 9 Summary - Johnson & Johnson SpA (Janssen-Cilag SpA): Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 22 Johnson & Johnson SpA (Janssen-Cilag SpA): Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• NOVARTIS CONSUMER HEALTH SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 10 Summary - Novartis Consumer Health SpA : Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 23 Novartis Consumer Health SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• PERFETTI VAN MELLE SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 24 Perfetti Van Melle: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• PFIZER CONSUMER HEALTHCARE SRL - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 11 Summary - Pfizer Consumer Healthcare Srl: Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 25 Pfizer Consumer Healthcare Srl: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• PROCTER & GAMBLE ITALIA SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 12 Summary - Procter & Gamble Italia SpA: Operational Indicators 2004
• PRODUCTION CAPACITY
• COMPETITIVE POSITIONING
  • Table 26 Procter & Gamble Italia SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - OTC
• HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 13 Summary - Recordati Industria Chimica e Farmaceutica SpA Operational Indicators 2004
• PRODUCTION CAPACITY
  • Summary 14 Summary - Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2003
• COMPETITIVE POSITIONING
  • Table 27 Recordati Industria Chimica e Farmaceutica SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• ROEDER 1956 FARMACEUTICI SNC - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• SANOFI-AVENTIS SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 15 Summary - Sanofi-Synth abo SpA Operational Indicators 2004
• PRODUCTION CAPACITY
  • Summary 16 Summary - Sanofi-Aventis SpA: Production Statistics 2004
• COMPETITIVE POSITIONING
  • Table 28 Sanofi-Aventis SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• SPECCHIASOL SPA - OTC HEALTHCARE - ITALY
• COMPANY REVIEW
• ZAMBON ITALIA SPA - OTC HEALTHCARE - ITALY
• COMPANY BACKGROUND
  • Summary 17 Summary - Zambon Group: Operational Indicators 2004
• PRODUCTION CAPACITY
  • Summary 18 Summary - Zambon Italia SpA: Production Statistics 2004
• COMPETITIVE POSITIONING
  • Table 29 Zambon Italia SpA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
• ANALGESICS IN ITALY
• SECTOR PERFORMANCE
• Good flu season boosts growth
• Consumers ignorance regarding generic products
• Pharmacies still control distribution
• Topical analgesics increase their share of analgesics as patches increase in popularity
• Adult analgesics -- flu provokes growth
• Naproxen enjoys good growth due to investment
• Ketoprofen going well thanks to Ketodol
• Steady performance from ibuprofen
• Child-specific analgesics
• Forecast performance -- topical analgesics expected to increase sales steadily
• Aspirin to continue downturn
• Child-specific analgesics expected to enjoy strong growth in coming years
• Acetaminophen' s performance closely linked to flu incidence
• Switch from Ibuprofen to Ketoprofen
• Naproxen sector is a growing niche
• Italians do not like combination products
  • Table 30 Sales of Analgesics by Subsector: Value 2000-2005
  • Table 31 Sales of Analgesics by Subsector: % Value Growth 2000-2005
  • Table 32 Analgesics Company Shares by Retail Value 2001-2005
  • Table 33 Analgesics Brand Shares by Retail Value 2002-2005
  • Table 34 Forecast Sales of Analgesics by Subsector: Value 2005-2010
  • Table 35 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• New launches in topical analgesics
• 2004 sees new acetaminophen products
  • Summary 19 Summary - Analgesics: New Product Launches 2004-2005
• TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
• Herbal products remain marginal
  • Table 36 Herbal vs Standard Topical Analgesics 2000/2005
• COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY
• SECTOR PERFORMANCE
• Good year for flu has positive impact on sales in 2005
• Cough and cold dominated by cough products
• Antihistamines continue to see growth
• Changing laws influence growth of OTC antihistamines
• Reactine, a winner
• Combination products grow strongly
• Pharyngeal preparations win out over medicated confectionery for once
• Forecast performance
• Lack of prevention culture will result in continued slow growth of antihistamines
• Cough remedies' growth closely linked to flu
• Combination products versus cough remedies
• Pharyngeal preparations versus medicated confectionary
  • Table 37 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
  • Table 38 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
  • Table 39 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
  • Table 40 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
  • Table 41 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
  • Table 42 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• Little activity
  • Summary 20 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
• COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
  • Table 43 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
• DECONGESTANTS PERFORMANCE
• Decongestants not performing particularly well
• Nasal decongestant plasters very dynamic
• Decongestant rubs see good year
• Nasal sprays see quite poor performance
• Nasal decongestant drops the second most valuable
• Worst performance from oral decongestants
• Inhalant decongestants still a small niche
• Decongestants likely to suffer further decline
  • Table 44 Sales of Decongestants by Type: Value 2000-2005
  • Table 45 Sales of Decongestants by Type: % Value Growth 2000-2005
• CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER)
• REMEDIES PERFORMANCE
• Child-specific cough and cold suffer slight decrease due to new law
• Slow future growth
  • Table 46 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
  • Table 47 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
• DIGESTIVE REMEDIES IN ITALY
• SECTOR PERFORMANCE
• "Natural is better"
• Unhealthy laxatives
• Diarrhoeal remedies -- a limited niche
• Motion sickness -- new competition
• Antacids suffer again
• Forecast performance -- new products expected
  • Table 48 Sales of Digestive Remedies by Subsector: Value 2000-2005
  • Table 49 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
  • Table 50 Digestive Remedies Company Shares by Retail Value 2001-2005
  • Table 51 Digestive Remedies Brand Shares by Retail Value 2002-2005
  • Table 52 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
  • Table 53 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• Activity focused on natural products
  • Summary 21 Summary - Digestive Remedies: New Product Launches 2004-2005
• DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
• Awaiting the new law
  • Table 54 Herbal vs Standard Digestive Remedies 2000/2005
• OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
• Antacids and digestives? No, thank you
• The recovery of antiflatulents
• Competition for motion sickness remedies
• Irritable bowel syndrome
• Child-specific products remain a niche
• A crowded environment
  • Table 55 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
  • Table 56 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
• MEDICATED SKIN CARE IN ITALY
• SECTOR PERFORMANCE
• Steady positive growth in 2005
• New hope for acne treatments
• Increasing use of OTC antipruritics
• The end of the decline for topical germicidals/antiseptics
• Another bad summer
• Positive topical antifungals, disappointing medicated shampoos
• Significant incidence of pediculosis
• The increasing importance of hair loss treatments
• Poor lifestyles and eating habits favour haemorrhoid treatments
• Demand up for nappy (diaper) rash treatments
• Fragmented environment
• Forecast performance -- OTC medicated skin care products to grow
  • Table 57 Sales of Medicated Skin Care by Subsector: Value 2000-2005
  • Table 58 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
  • Table 59 Medicated Skin Care Company Shares by Retail Value 2001-2005
  • Table 60 Medicated Skin Care Brand Shares by Retail Value 2002-2005
  • Table 61 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
  • Table 62 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• Few innovations
  • Summary 22 Summary - Medicated Skin Care: New Product Launches 2004-2005
• MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
• Awaiting the new law
  • Table 63 Herbal vs Standard Medicated Skin Care 2000/2005
• ACNE TREATMENTS BRAND SHARES
• Acne treatments -- the importance of advertising
  • Table 64 Acne Treatments Brand Shares by Retail Value 2002-2005
• HAIR LOSS TREATMENTS BRAND SHARES
• A new competitor in this specialist area
  • Table 65 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
• VITAMINS AND DIETARY SUPPLEMENTS IN ITALY
• HEALTHY PERFORMANCE IN 2005
• Vitamins still enjoying growth
• The success of ' natural' dietary supplements
• Tonics and nutritive bottled drinks face off against multivitamins
• The increasing importance of child-specific products
• Whitehall and Roche still the leaders
• Forecast performance -- further growth expected
• Success of multivitamins to grow
• Dietary supplements to perform positively
• Mineral supplements to recover
• Fish oil, gingko biloba and propoli, all to see good growth...
• .as well as other innovative products
• Probiotic supplements to continue their popularity
• The new status of St John' s wort
• Older products mostly used in combinations
  • Table 66 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
  • Table 67 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
  • Table 68 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
  • Table 69 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
  • Table 70 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
  • Table 71 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• A very dynamic environment
  • Summary 23 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
• VITAMINS PERFORMANCE
• Multivitamins see growth, but demand still determined by weather conditions
• Some vitamins are only available on prescription
• Vitamin B growth due to its great importance
• Vitamin C sales linked to seasonal ailments
• Steady growth in vitamin E
  • Table 72 Retail Sales of Multivitamins by Type: % Analysis 2001-2005
  • Table 73 Sales of Vitamins by Type: Value 2000-2005
  • Table 74 Sales of Vitamins by Type: % Value Growth 2000-2005
• DIETARY SUPPLEMENTS PERFORMANCE
• Decline suffered by calcium
• Mineral supplements are still largely seasonal
• The properties of fish oils are greatly appreciated
• Lecithin in decline
• New confidence in herbal supplements
• Stable demand for garlic and fibre supplements
• Positive ginseng and ginkgo biloba
• Echinacea -- a new immunostimulant
• St John' s wort is now RX only
• Healthy probiotic supplements
• The growth of eye care
• Royal jelly crisis has only partial influence on propoli
• Co-enzyme Q10 and glucosamine -- good for an ageing population
• Combination products enjoying great success
• An increasingly crowded environment
  • Table 75 Sales of Dietary Supplements by Type: Value 2000-2005
  • Table 76 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
  • Table 77 Dietary Supplements Brand Shares by Retail Value 2002-2005
  • Table 78 Dietary Supplements by Positioning: % Retail Value Analysis 2005
• NRT SMOKING CESSATION AIDS IN ITALY
• NUMBER OF SMOKERS
• The new law on smoking
  • Table 79 Distribution of Italian Smokers by Gender and Frequency 2005
  • Table 80
• SECTOR PERFORMANCE
• Success of smoking cessation aids due to the law banning smoking
• An important new entry
• Forecast performance -- legislation helping
  • Table 81 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
  • Table 82 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
  • Table 83 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
  • Table 84 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• The new GlaxoSmithKline approach
  • Summary 24 Summary - NRT Smoking Cessation Aids: New Product Launches 2004-2005
• EYE CARE IN ITALY
• SECTOR PERFORMANCE
• A not very brilliant 2005
• A very fragmented market
• Forecast performance -- an innovative environment driven by natural and single-dose products
  • Table 87 Sales of Eye Care by Subsector: Value 2000-2005
  • Table 88 Sales of Eye Care by Subsector: % Value Growth 2000-2005
  • Table 89 Eye Care Company Shares by Retail Value 2001-2005
  • Table 90 Eye Care Brand Shares by Retail Value 2002-2005
  • Table 91 Forecast Sales of Eye Care by Subsector: Value 2005-2010
  • Table 92 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• A lull after a number of launches
  • Summary 25 Summary - Eye Care: New Product Launches 2004-2005
• EAR CARE IN ITALY
• SECTOR PERFORMANCE
• Ear care -- not a lot of interest
• ADULT MOUTHCARE IN ITALY
• SECTOR PERFORMANCE
• Positive performance from adult mouthcare
• CALMING AND SLEEPING PRODUCTS IN ITALY
• SECTOR PERFORMANCE
• Another modest year for calming and sleeping products
• WOUND TREATMENTS IN ITALY
• SECTOR PERFORMANCE
• Innovation drives growth
• Great progress made by plasters
• Strong growth from Beiersdorf
• Forecast performance -- innovation to drive further growth from plasters
  • Table 93 Sales of Wound Treatments by Subsector: Value 2000-2005
  • Table 94 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
  • Table 95 Wound Treatments Company Shares by Retail Value 2001-2005
  • Table 96 Wound Treatments Brand Shares by Retail Value 2002-2005
  • Table 97 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
  • Table 98 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
• NEW PRODUCT DEVELOPMENTS
• New plasters
  • Summary 26 Summary - Wound Treatments: New Product Launches 2004-2005
• EMERGENCY CONTRACEPTION IN ITALY
• SECTOR PERFORMANCE